The Heart Failure Society of America (HFSA) and XpertDox announced a partnership to leverage the XpertDox product, XpertTrial, a clinical trial search and engagement platform. The XpertTrial platform will provide patients and providers with the most up-to-date information regarding actively-recruiting, U.S.-based heart failure related clinical trials.
"This important initiative builds on our efforts to improve and expand heart failure care through collaboration, education, innovation, research, and advocacy," said Dr. Christopher O'Connor, MD, FHFSA, President of The Heart Failure Society of America. "We are pleased to partner with XpertDox and are excited to leverage their XpertTrial platform to promote current heart failure clinical trials; provide a centralized location for heart failure patients; caregivers; and providers to engage with on-going clinical trials and; increase understanding of available heart failure clinical trials and recruitment criteria."
"The XpertTrial Platform has been designed specifically to accelerate access to clinical trial data and provide the information necessary to make informed decisions. This collaboration will enable users to easily search for information, identify clinical trial opportunities and access the latest heart failure research," Dr. Sameer Ather, MD, PhD, CEO and co-founder of XpertDox said. "HFSA adds tremendous value to heart failure specialists, patients and caregivers and we are proud to partner with them."
XpertTrial is a natural language processing search engine that can match more than 70,000 keywords to all actively recruiting clinical trials across all diseases, procedures, symptoms, and specialties. This powerful clinical trial search engine harnesses a proprietary algorithm that leverages big data to generate network mapping between diseases, procedures and clinical trials.